Stroke COunseling for Risk REduction

NCT ID: NCT03076125

Last Updated: 2018-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

116 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2017-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the efficacy of the Stroke Counseling for Risk Reduction (SCORRE) intervention in increasing accuracy of perceived stroke risk and promoting lifestyle behavior change to reduce stroke risk in young adult African Americans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Primary Stroke Prevention, Risk Factors for Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled two-group pre-post test design
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors
data collectors conducting post-intervention and 8-week follow up are blinded to participant treatment groups

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SCORRE group

Stroke risk factor brochure, stroke champions video, counseling on accuracy of perceived stroke risk and strategies to reduce stroke risk, weekly motivational health behavior tips (for physical activity, diet, or smoking cessation) text messages for 8 weeks.

Group Type EXPERIMENTAL

SCORRE

Intervention Type BEHAVIORAL

3 components based on the Health Belief Model

Attention Control Group

Sexual health education brochure and Safe in the City video, weekly sexual health tips text messages for 8 weeks.

Group Type SHAM_COMPARATOR

Attention-Control Activity

Intervention Type BEHAVIORAL

sexual health education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SCORRE

3 components based on the Health Belief Model

Intervention Type BEHAVIORAL

Attention-Control Activity

sexual health education

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* self-identify as African American/Black
* age 20-35 years
* able to complete two study visits lasing 1 1/2- 2 hours and a brief daily diary for 8 weeks
* has a cell phone or email address to receive weekly reminders and tips
* has at least one modifiable risk factor for stroke identified during study visit one screening
Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Georgia State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dawn Aycock

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Georgia State University

Atlanta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K01NR015494

Identifier Type: NIH

Identifier Source: org_study_id

View Link